{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:11:36Z","timestamp":1787062296058,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5-T32-EB004311-19"],"award-info":[{"award-number":["5-T32-EB004311-19"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA-278882"],"award-info":[{"award-number":["R01-CA-278882"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA267560"],"award-info":[{"award-number":["R00CA267560"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijrobp.2025.05.085","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:58:33Z","timestamp":1750503513000},"page":"656-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted \u03b1-Particle Therapy With Astatine 211-ParaThanatrace"],"prefix":"10.1016","volume":"123","author":[{"given":"Victor V.","family":"Onecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Suarez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas J.","family":"Bosque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Simpkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-693X","authenticated-orcid":false,"given":"Alejandro","family":"Bertolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.05.085_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: Clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0002","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current status of radiopharmaceutical therapy","volume":"109","author":"St James","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0003","article-title":"Efficacy and safety of 225Ac-PSMA-617-Targeted alpha therapy in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis","volume":"12","author":"Ma","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0004","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2022.08.010","article-title":"A primer on radiopharmaceutical therapy","volume":"115","author":"Salerno","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.semradonc.2023.03.011","article-title":"Theranostics and patient-specific dosimetry","volume":"33","author":"Bednarz","year":"2023","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semradonc.2020.07.008","article-title":"Dosimetry for optimized, personalized radiopharmaceutical therapy","volume":"31","author":"Graves","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1667\/RADE-20-00045.1","article-title":"An analytical microdosimetric model for radioimmunotherapeutic alpha emitters","volume":"194","author":"Bertolet","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0009","article-title":"Microdosimetry for targeted alpha therapy of cancer","volume":"2012","author":"Huang","year":"2012","journal-title":"Comp Math Methods Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU Report 96, Dosimetry-Guided Radiopharmaceutical Therapy","volume":"21","author":"Sgouros","year":"2022","journal-title":"J ICRU"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet No. 21: A generalized schema for radiopharmaceutical dosimetry\u2014standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2967\/jnmt.123.265668","article-title":"The MIRD schema for radiopharmaceutical dosimetry: A review","volume":"52","author":"Zanzonico","year":"2024","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0013","first-page":"1965","article-title":"MIRD Pamphlet No. 31: MIRDcell V4\u2014artificial intelligence tools to formulate optimized radiopharmaceutical cocktails for therapy","volume":"65","author":"Katugampola","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0014","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2967\/jnumed.123.266571","article-title":"Beyond average: \u03b1-particle distribution and dose heterogeneity in bone metastatic prostate cancer","volume":"65","author":"Benabdallah","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0015","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00259-022-05821-w","article-title":"In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T","volume":"49","author":"Ruigrok","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12967-023-03991-1","article-title":"Large-scale in vitro microdosimetry via live cell microscopy imaging: Implications for radiosensitivity and RBE evaluations in alpha-emitter radiopharmaceutical therapy","volume":"21","author":"Bastiaannet","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0017","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1118\/1.4758060","article-title":"TOPAS: An innovative proton Monte Carlo platform for research and clinical applications","volume":"39","author":"Perl","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmp.2020.03.019","article-title":"The TOPAS tool for particle simulation, a Monte Carlo simulation tool for physics, biology and clinical research","volume":"72","author":"Faddegon","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0019","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0168-9002(03)01368-8","article-title":"Geant4\u2014a simulation toolkit","volume":"506","author":"Agostinelli","year":"2003","journal-title":"Nucl Instrum Methods Phys Res Sect A"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0020","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/acs.orglett.8b00232","article-title":"Rapid Cu-catalyzed [211At]astatination and [125I]iodination of boronic esters at room temperature","volume":"20","author":"Reilly","year":"2018","journal-title":"Org Lett"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0021","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s42003-022-04209-8","article-title":"Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma","volume":"5","author":"Makvandi","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0022","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.radphyschem.2009.03.079","article-title":"A free-parameter theoretical model for describing the electron elastic scattering in water in the Geant4 toolkit","volume":"78","author":"Champion","year":"2009","journal-title":"Radiat Phys Chem"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejmp.2015.10.087","article-title":"Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit","volume":"31","author":"Bernal","year":"2015","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0024","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1158\/0008-5472.CAN-16-0416","article-title":"A radiotracer strategy to quantify PARP-1 expression in vivo provides a biomarker that can enable patient selection for PARP inhibitor therapy","volume":"76","author":"Makvandi","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0025","unstructured":"Berger MJ, Coursey JS, Zucker MA, et al. ESTAR, PSTAR and ASTAR: Computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 2.0.1). NIST Standard Reference Database 124. 2017. Available at: https:\/\/www.nist.gov\/pml\/stopping-power-range-tables-electrons-protons-and-helium-ions. Accessed July 7, 2025."},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0026","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00259-024-06719-5","article-title":"Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?","volume":"51","author":"Kleynhans","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0027","first-page":"1846","article-title":"The translation of dosimetry into clinical practice: What it takes to make dosimetry a mandatory part of clinical practice","volume":"65","author":"Bardi\u00e8s","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1269\/jrr.07123","article-title":"Formation of clustered DNA damage after high-LET irradiation: A review","volume":"49","author":"Hada","year":"2008","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0029","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3390\/ijms21186602","article-title":"Comparison of high- and low-LET radiation-induced DNA double-strand break processing in living cells","volume":"21","author":"Roobol","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0030","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/pharmaceutics15122761","article-title":"DNA damage by radiopharmaceuticals and mechanisms of cellular repair","volume":"15","author":"Khazaei Monfared","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0031","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1667\/RR14766.1","article-title":"Cellular response to exponentially increasing and decreasing dose rates: Implications for treatment planning in targeted radionuclide therapy","volume":"188","author":"Solanki","year":"2017","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0032","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1535-7163.MCT-21-1021","article-title":"Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer","volume":"21","author":"Rodak","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nucmedbio.2020.08.003","article-title":"Preclinical evaluation of new \u03b1-radionuclide therapy targeting LAT1: 2-[211At]astato-\u03b1-methyl-L-phenylalanine in tumor-bearing model","volume":"90-91","author":"Ohshima","year":"2020","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0034","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2967\/jnumed.122.264071","article-title":"Effective treatment of human breast carcinoma xenografts with single-dose 211At-labeled anti-HER2 single-domain antibody fragment","volume":"64","author":"Feng","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116600","article-title":"In vitro and in vivo evaluation of 211At-labeled fibroblast activation protein inhibitor for glioma treatment","volume":"55","author":"Ma","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0036","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.7150\/thno.78043","article-title":"Modulating the pharmacokinetic profile of actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin","volume":"12","author":"Reissig","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0037","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1007\/s00259-022-05878-7","article-title":"Predicting response of micrometastases with MIRDcell V3: Proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids","volume":"49","author":"Katugampola","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0038","first-page":"761","article-title":"Modeling early radiation DNA damage occurring during 177Lu-DOTATATE radionuclide therapy","volume":"63","author":"Tamborino","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0039","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.7150\/thno.82101","article-title":"Imaging DNA damage response by \u03b3H2AX in vivo predicts treatment response to lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome","volume":"13","author":"O\u2019Neill","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11095-014-1462-8","article-title":"Quantitative measurement of the target-mediated internalization kinetics of biopharmaceuticals","volume":"32","author":"Vainshtein","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0041","series-title":"Peptide, Protein and Enzyme Design. Methods in Enzymology","first-page":"21","article-title":"Cell-binding assays for determining the affinity of protein-protein interactions: Technologies and considerations","author":"Hunter","year":"2016"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0042","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/abf29f","article-title":"TOPAS a tool to evaluate the impact of cell geometry and radionuclide on alpha particle therapy","volume":"7","author":"Guerra Liberal","year":"2021","journal-title":"Biomed Phys Eng Express"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1196502","article-title":"The complexity of DNA damage by radiation follows a Gamma distribution: Insights from the microdosimetric gamma model","volume":"13","author":"Bertolet","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.05.085_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2023.1284558","article-title":"A fast Monte Carlo cell-by-cell simulation for radiobiological effects in targeted radionuclide therapy using pre-calculated single-particle-track standard DNA damage data","volume":"3","author":"Lim","year":"2023","journal-title":"Front Nucl Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625039057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625039057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:58:56Z","timestamp":1778687936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625039057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0360301625039057"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.085","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted \u03b1-Particle Therapy With Astatine 211-ParaThanatrace","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}